vs
CALAVO GROWERS INC（CVGW）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
CALAVO GROWERS INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.8倍（$124.7M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 3.1%，领先381.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -26.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -1.2%）
卡拉沃种植者公司是一家国际化农产消费品企业，核心业务涉及牛油果及其他鲜果、新鲜预制食品的包装与分销，产品面向全球各地的餐饮门店、零售卖场以及个人客户供应，是生鲜果蔬领域颇具规模的供应商。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CVGW vs RIGL — 直观对比
营收规模更大
CVGW
是对方的1.8倍
$69.8M
营收增速更快
RIGL
高出47.8%
-26.6%
净利率更高
RIGL
高出381.0%
3.1%
两年增速更快
RIGL
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $124.7M | $69.8M |
| 净利润 | $3.8M | $268.1M |
| 毛利率 | 9.3% | 91.5% |
| 营业利润率 | -1.4% | 33.2% |
| 净利率 | 3.1% | 384.0% |
| 营收同比 | -26.6% | 21.2% |
| 净利润同比 | 2846.0% | 1769.2% |
| 每股收益（稀释后） | $0.22 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVGWRIGL
| Q4 25 | $124.7M | $69.8M | ||
| Q3 25 | $178.8M | $69.5M | ||
| Q2 25 | $190.5M | $101.7M | ||
| Q1 25 | $154.4M | $53.3M | ||
| Q4 24 | $170.0M | $57.6M | ||
| Q3 24 | $179.6M | $55.3M | ||
| Q2 24 | $184.4M | $36.8M | ||
| Q1 24 | $127.6M | $29.5M |
净利润CVGWRIGL
| Q4 25 | $3.8M | $268.1M | ||
| Q3 25 | $4.7M | $27.9M | ||
| Q2 25 | $6.8M | $59.6M | ||
| Q1 25 | $4.4M | $11.4M | ||
| Q4 24 | $-139.0K | $14.3M | ||
| Q3 24 | $-732.0K | $12.4M | ||
| Q2 24 | $6.1M | $-1.0M | ||
| Q1 24 | $-6.3M | $-8.2M |
毛利率CVGWRIGL
| Q4 25 | 9.3% | 91.5% | ||
| Q3 25 | 10.2% | 93.2% | ||
| Q2 25 | 9.5% | 95.6% | ||
| Q1 25 | 10.2% | 91.7% | ||
| Q4 24 | 9.7% | 89.9% | ||
| Q3 24 | 11.2% | 85.5% | ||
| Q2 24 | 11.1% | 92.4% | ||
| Q1 24 | 8.4% | 93.1% |
营业利润率CVGWRIGL
| Q4 25 | -1.4% | 33.2% | ||
| Q3 25 | 4.8% | 40.9% | ||
| Q2 25 | 4.0% | 60.1% | ||
| Q1 25 | 3.3% | 23.9% | ||
| Q4 24 | 1.8% | 28.9% | ||
| Q3 24 | 5.2% | 25.4% | ||
| Q2 24 | 4.0% | 1.2% | ||
| Q1 24 | -2.4% | -23.6% |
净利率CVGWRIGL
| Q4 25 | 3.1% | 384.0% | ||
| Q3 25 | 2.6% | 40.2% | ||
| Q2 25 | 3.6% | 58.6% | ||
| Q1 25 | 2.9% | 21.5% | ||
| Q4 24 | -0.1% | 24.9% | ||
| Q3 24 | -0.4% | 22.5% | ||
| Q2 24 | 3.3% | -2.8% | ||
| Q1 24 | -4.9% | -27.9% |
每股收益（稀释后）CVGWRIGL
| Q4 25 | $0.22 | $14.11 | ||
| Q3 25 | $0.26 | $1.46 | ||
| Q2 25 | $0.38 | $3.28 | ||
| Q1 25 | $0.25 | $0.63 | ||
| Q4 24 | $-0.01 | $0.82 | ||
| Q3 24 | $-0.04 | $0.70 | ||
| Q2 24 | $0.34 | $-0.06 | ||
| Q1 24 | $-0.35 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $61.2M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $206.9M | $391.5M |
| 总资产 | $292.2M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CVGWRIGL
| Q4 25 | $61.2M | $155.0M | ||
| Q3 25 | $63.8M | $137.1M | ||
| Q2 25 | $60.4M | $108.4M | ||
| Q1 25 | $48.5M | $77.1M | ||
| Q4 24 | $57.0M | $77.3M | ||
| Q3 24 | $1.1M | $61.1M | ||
| Q2 24 | $4.3M | $49.1M | ||
| Q1 24 | $5.7M | $49.5M |
总债务CVGWRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CVGWRIGL
| Q4 25 | $206.9M | $391.5M | ||
| Q3 25 | $206.4M | $117.6M | ||
| Q2 25 | $206.6M | $81.9M | ||
| Q1 25 | $202.9M | $18.6M | ||
| Q4 24 | $200.3M | $3.3M | ||
| Q3 24 | $205.2M | $-14.6M | ||
| Q2 24 | $207.3M | $-29.9M | ||
| Q1 24 | $202.5M | $-31.7M |
总资产CVGWRIGL
| Q4 25 | $292.2M | $513.6M | ||
| Q3 25 | $301.2M | $242.5M | ||
| Q2 25 | $321.5M | $206.7M | ||
| Q1 25 | $298.9M | $176.0M | ||
| Q4 24 | $301.1M | $164.0M | ||
| Q3 24 | $382.4M | $139.4M | ||
| Q2 24 | $411.4M | $128.4M | ||
| Q1 24 | $394.7M | $126.5M |
负债/权益比CVGWRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $1.2M | — |
| 自由现金流率自由现金流/营收 | 1.0% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 0.60× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $19.4M | — |
8季度趋势，按日历期对齐
经营现金流CVGWRIGL
| Q4 25 | $2.3M | $22.0M | ||
| Q3 25 | $8.0M | $24.0M | ||
| Q2 25 | $15.7M | $30.5M | ||
| Q1 25 | $-4.4M | $-893.0K | ||
| Q4 24 | $10.8M | $14.5M | ||
| Q3 24 | $11.4M | $21.7M | ||
| Q2 24 | $2.1M | $302.0K | ||
| Q1 24 | $58.0K | $-5.0M |
自由现金流CVGWRIGL
| Q4 25 | $1.2M | — | ||
| Q3 25 | $7.3M | — | ||
| Q2 25 | $15.6M | — | ||
| Q1 25 | $-4.7M | — | ||
| Q4 24 | $10.5M | — | ||
| Q3 24 | $11.3M | — | ||
| Q2 24 | $745.0K | — | ||
| Q1 24 | $-972.0K | — |
自由现金流率CVGWRIGL
| Q4 25 | 1.0% | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 8.2% | — | ||
| Q1 25 | -3.1% | — | ||
| Q4 24 | 6.2% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | -0.8% | — |
资本支出强度CVGWRIGL
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.8% | — |
现金转化率CVGWRIGL
| Q4 25 | 0.60× | 0.08× | ||
| Q3 25 | 1.69× | 0.86× | ||
| Q2 25 | 2.29× | 0.51× | ||
| Q1 25 | -1.00× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVGW
| Fresh Products | $104.7M | 84% |
| Segment Prepared | $14.5M | 12% |
| Tomatoes | $4.6M | 4% |
RIGL
暂无分部数据
